In vivo 31 P MR spectral patterns and reproducibility in cancer patients studied in a multi-institutional trial

NMR in Biomedicine

Volumn 19, Issue 4, 2006, Pages 504-512

  Arias Mendoza, F ^a,b   Payne, G S ^d   Zakian, K L ^c   Schwarz, A J ^d   Stubbs, M ^e   Stoyanova, R ^b   Ballon, D ^c   Howe, F A ^e   Koutcher, J A ^c   Leach, M O ^d   Griffiths, J R ^e   Heerschap, A ^f   Glickson, J D ^g   Nelson, S J ^h   Evelhoch, J L ⁱ   Charles, H C ^j   Brown, T R ^b   Cruz Lobo, J ^b   Murphy Boesch, J ^b   Negendank, W G ^b   Shukla Dave, A ^c   Oregioni, A ^d   Collins, D J ^d   Maisey, N R ^d   Ronen, Sabrina ^d   Doyle, Victoria L ^e   Rijpkema, Mark ^f   Poptani, H ^g   Lenkinski, R E ^g   Vigneron, D B ^h   Hu, Jiani ⁱ   more..

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b FOX CHASE CANCER CENTER   (United States)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^d Royal Marsden Hospital   (United Kingdom)

^e ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^f RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^g UNIVERSITY OF PENNSYLVANIA   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ WAYNE STATE UNIVERSITY   (United States)

^j DUKE UNIVERSITY   (United States)

more..

Author keywords

Breast carcinomas; Cancer; Head and neck carcinomas; Localized 31 P MR spectroscopy; Multi institutional group; Non Hodgkin's lymphomas; Non invasive; Phosphocholine; Phosphoethanolamine; Reproducibility; Sarcomas of soft tissue and bone

Indexed keywords

BONE; MAGNETIC RESONANCE SPECTROSCOPY; PATIENT TREATMENT; SPECTRUM ANALYSIS; TISSUE; TUMORS;

BREAST CARCINOMAS; MULTI-INSTITUTIONAL TRIAL; NON-HODGKIN'S LYMPHOMAS; NUCLEOTIDE TRIPHOSPHATES; PHOSPHOCHOLINE; PHOSPOETHANOLAMINE;

ONCOLOGY;

NUCLEOTIDE; PHOSPHOETHANOLAMINE; PHOSPHORUS 31; PHOSPHORYLCHOLINE; DIAGNOSTIC AGENT; PHOSPHORUS; PHOSPHORUS DERIVATIVE; TUMOR MARKER;

ANALYTICAL ERROR; ARTICLE; BREAST CARCINOMA; CANCER PATIENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEASIBILITY STUDY; HEAD AND NECK CARCINOMA; HUMAN; IMAGE ANALYSIS; IMAGE DISPLAY; IMAGE QUALITY; INFORMATION PROCESSING; INTERNATIONAL COOPERATION; MAJOR CLINICAL STUDY; MALIGNANT NEOPLASTIC DISEASE; MULTICENTER STUDY; NON INVASIVE MEASUREMENT; NONHODGKIN LYMPHOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOSARCOMA; PATHOLOGICAL ANATOMY; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PREDICTION; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; REPRODUCIBILITY; SAMPLE SIZE; SOFT TISSUE SARCOMA; STANDARDIZATION; STATISTICAL ANALYSIS; TREATMENT OUTCOME; TUMOR LOCALIZATION; COMPUTER ASSISTED DIAGNOSIS; METABOLISM; METHODOLOGY; NEOPLASM; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; SENSITIVITY AND SPECIFICITY; UNITED STATES;

VICIA SATIVA;

DIAGNOSIS, COMPUTER-ASSISTED; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; NEOPLASMS; PHOSPHORUS; PHOSPHORUS COMPOUNDS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL; UNITED STATES;

EID: 33745726463     PISSN: 09523480     EISSN: 10991492     Source Type: Journal    
DOI: 10.1002/nbm.1057     Document Type: Article

References (13)

1. Arias-Mendoza F, Zakian K, Schwartz A, Howe FA, Koutcher JA, Leach MO, Griffiths JR, Heerschap, A, Glickson JD, Nelson SJ, Evelhoch JL, Charles HC, Brown TR. Methodological standardization for a multi-institutional in vivo trial of localized (31)P MR spectroscopy in human cancer research. In vitro and normal volunteer studies. NMR Biomed. 2004; 17: 382.
2. Arias-Mendoza F, Smith MR, Brown TR. Predicting treatment response in non-Hodgkin's lymphoma from the pretreatment tumor content of phosphoethanolamine plus phosphocholine. Acad. Radiol. 2004; 11: 368-376.
3. Murphy-Boesch J, Jiang H, Stoyanova R, Brown TR. Quantification of phosphorus metabolites from chemical shift imaging spectra with corrections for point spread effects and B1 inhomogeneity. Magn. Reson. Med. 1998; 39: 429-438.
4. 31P MRS of the head and neck region. Magn. Reson. Imaging 2001; 19: 755-759.
5. 31p spectroscopy of the human head. J. Magn. Reson. B 1994; 103: 103-114.
6. Brown TR. Practical applications of chemical shift imaging. NMR Biomed. 1992; 5: 238-243.
7. Brown TR, Kincaid BM, Ugurbil K. NMR chemical shift imaging in three dimensions. Proc. Natl. Acad. Sci. USA 1982; 79: 3523-3526.
8. 31P chemical shift imaging of the human brain in normal volunteers. NMR Biomed. 1993; 6: 173-180.
9. Negendank WG, al-Katib AM, Karanes C, Smith MR. Lymphomas: MR imaging contrast characteristics with clinical-pathologic correlations. Radiology 1990; 177: 209-216.
10. Li CW, Kuesel AC, Padavic-Shaller KA, Murphy-Boesch J, Eisenberg BL, Schmidt RG, von Roemeling RW, Patchefsky AS, Brown TR, Negendank WG. Metabolic characterization of human soft tissue sarcomas in vivo and in vitro using proton-decoupled phosphorus magnetic resonance spectroscopy. Cancer Res. 1996; 56: 2964-2972.
11. 1, relaxation times of phosphorylated metabolites in human calf muscle at 1.5 tesla. Magn. Reson. Med. 1995; 33: 417-421.
12. Vigneron DB, Nelson SJ, Murphy-Boesch J, Kelley DA, Kessler HB, Brown TR, Taylor JS. Chemical shift imaging of human brain: axial, sagittal and coronal P-31 metabolite images. Radiology 1990; 177: 643-649.
13. Franks SE, Smith MR, Arias-Mendoza F, Shaller C, Padavic-Shaller K, Kappler F, Zhang Y, Negendank WG, Brown TR. Phosphomonoester concentrations differ between chronic lymphocytic leukemia cells and normal human lymphocytes. Leuk. Res. 2002; 26: 919-926.